Atara Biotherapeutics, Inc. (ATRA) Operating margin 2022–2025
Atara Biotherapeutics, Inc. (ATRA) operating margin by fiscal year — reported operating income divided by reported revenue.
29.7%FY2025 · since FY2022: -441.2% → 29.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.7% | +94.4 pp |
| FY2024 | -64.7% | +3154.8 pp |
| FY2023 | -3219.5% | -2778.2 pp |
| FY2022 | -441.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice